Remove executives
article thumbnail

Gilead writes $2.4B off Trodelvy as CEO underscores ‘time of focused execution’

Fierce Pharma

With a busy year ahead across therapeutic areas, CEO Dan O'Day emphasized a "time of focused execution." . | After a negative phase 3 readout, Gilead Sciences is taking a $2.4 billion impairment charge on the antibody-drug conjugate Trodelvy.

193
193
article thumbnail

Lonza appoints new Chief Executive

European Pharmaceutical Review

Baehny has held his Chief Executive Officer ad interim role since October 2023 and will support Wienand through the transition period. The post Lonza appoints new Chief Executive appeared first on European Pharmaceutical Review. Wienand will join the contract development and manufacturing organisation (CDMO) in the summer of 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MHRA Chief Executive to step down

European Pharmaceutical Review

The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine, will step down in the Autumn following five years in the role. Dame June will remain in the position until then to support the new Chief Executive’s transition into the role.

article thumbnail

JPM24: Pfizer CEO promises 'year of execution' after recent struggles, Seagen buyout

Fierce Pharma

Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

Having a team of individuals with specialized expertise in different areas of clinical supply—including protocol review and early operational planning, to managing the development and execution of a sound clinical supply strategy—can prove invaluable to the overall suitability and performance of the supply chain, and in turn, the successful execution (..)

article thumbnail

Executive Interviews at Digital Pharma East 2023

Fierce Pharma

Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Learn more by watching the videos below. Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East.

Pharma 246
article thumbnail

EY: Health Executives Are Implementing Digital Health, But Aren’t Seeing ROI Yet

MedCity News

A new EY survey found that while 86% of health executives say that digital health solutions have the potential to reduce costs, 70% said they haven’t seen a return on investment so far.

125
125
article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and (..)

article thumbnail

12 Tips for Selling to the C-Suite

That’s why every salesperson’s goal is to make their pitch directly to a senior executive—ideally, sooner rather than later. Members of the C-suite are the key decision-makers when it comes to making major investments in their organizations. The following 12 tips can help ensure that you and your team are.

article thumbnail

The New GTM Playbook: 18 Ways to Future-Proof Your Sales Team

We’ve developed an entirely new way for GTM leaders to identify and execute proven, data-driven strategies that drive revenue. Go-to-market teams of every size, in every industry, are grappling with these challenges firsthand. Thankfully, there’s an answer.

article thumbnail

3 Mistakes Organizations Make While Developing ABM Programs

Download ZoomInfo’s latest eBook to learn about the three most common mistakes organizations make while executing an ABM program, including: Poor account selection process. Inadequate contact inventory within universe. Wasteful technology and service spending.

article thumbnail

ABM Evolution: How Top Marketers Are Using Account-Based Strategies

Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.

article thumbnail

What We Learned From Our Own Data-Driven ABM Strategy

talking points, we thought it would be more helpful to examine an ABM program that ZoomInfo executed. Instead of wading through a series of vague “how-to kick-start your ABM strategy!” In just 90 days, we were able to increase our pipeline by 114% and the customer base for this particular product by 30%.

article thumbnail

The Ultimate Guide to Executive Recruiting

That is why building a strong framework for executive hiring that maximizes efficiencies while minimizing cost and time to hire is important. Get ready to hire executives by downloading today! In this eBook, learn: The Discovery Processes. How to Source Talent. Ways to Reach Best-fit Candidates.